Topical Povidone-Iodine for Treatment of Giant Fornix Syndrome

Ophthalmic Plastic and Reconstructive Surgery
Kaveh Vahdani, Geoffrey E Rose

Abstract

Over a 2-year period, a 68-year-old woman suffered multiple recurrences of left giant fornix syndrome during the repeated tailing of intensive topical steroids and antibiotics; she had also undergone surgery to reduce the left upper fornix. After a further recurrence during tailing of topical therapy for bilateral disease, treatment with 4 times daily preservative-free povidone-iodine 5% eyedrops was started-with a marked improvement of symptoms and signs within a week. The patient is maintained, symptom-free, on once-daily povidone-iodine drops and dexamethasone 0.1% drops. The dramatic improvement on topical povidone-iodine therapy might suggest that, as an initial therapy, this might be more effective than the previously-recommended regime of hourly potent topical steroids and antibiotics.

References

Sep 25, 2007·Orbit·David RossmanGeoffrey E Rose
Jan 1, 2008·Journal of Cataract and Refractive Surgery·Christopher N TaHerminia Mino de Kaspar
Nov 29, 2012·Ophthalmic Plastic and Reconstructive Surgery·Cameron B NabaviMatthew G Vicinanzo
Jul 9, 2016·Ophthalmic Plastic and Reconstructive Surgery·Kaveh VahdaniVladimir Theodor Thaller
Oct 15, 2018·BMJ Case Reports·Rushmia KarimSteve Tuft

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Related Papers

Ophthalmology
Bataung Mokete, Graham M Thompson
Ophthalmic Plastic and Reconstructive Surgery
Kaveh VahdaniVladimir Theodor Thaller
Journal français d'ophtalmologie
A MaudinetS Bouakaz
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
Ophthalmic Surgery
T C White
© 2021 Meta ULC. All rights reserved